Autism Spectrum Disorder Trial, Recruiting (NCT06909279)

Autism Spectrum Disorder Trial, Recruiting NCT06909279 Sponsor: Western University, Canada Condition: Autism Spectrum Disorder

Printed from Voxsanity (voxsanity.com.au) — NCT06909279 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Autism Spectrum Disorder

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

The child is under 48 months (4 years) old at the time of joining the study.
The child has been assessed by a community speech-language pathologist (speech therapist) as having delays in social communication and play skills.
The family has access to a smartphone, tablet, or computer with a webcam and internet connection, for attending online sessions and completing study forms.
The parent or main caregiver is available to take part in a 13-week online program, which includes 9 group sessions held on Saturday mornings or Monday evenings.
The parent or main caregiver is comfortable communicating and filling out forms in English.

Who may not be able to join:

Children and families who do not meet all of the criteria listed above are not eligible to participate.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 519-661-2111

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06909279

Sponsor: Western University, Canada

Phase: Not Applicable

Status: Recruiting

Condition: Autism Spectrum Disorder

Trial contact: 519-661-2111

More information: https://clinicaltrials.gov/study/NCT06909279

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

The child is under 48 months (4 years) old at the time of joining the study.
The child has been assessed by a community speech-language pathologist (speech therapist) as having delays in social communication and play skills.
The family has access to a smartphone, tablet, or computer with a webcam and internet connection, for attending online sessions and completing study forms.
The parent or main caregiver is available to take part in a 13-week online program, which includes 9 group sessions held on Saturday mornings or Monday evenings.
The parent or main caregiver is comfortable communicating and filling out forms in English.

Who may not be able to join:

Children and families who do not meet all of the criteria listed above are not eligible to participate.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Western University, Canada

Registry

ClinicalTrials.gov

Start date

6 May 2025

Est. completion

1 April 2026

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Changes from baseline in Child Communicative Participation at post-program and follow-up; Changes from baseline in global social communication challenges at post-program and follow-up; Changes from baseline in joint engagement at post-program and follow-up; Changes from baseline in parent evaluation of self-efficacy and services at post-program and follow-up; Changes from baseline in child prelinguistic skills at post-program and follow-up; Changes from baseline in parent use of More Than Words strategies at post-program and follow-up

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov